Related Experiment Video
Updated: May 2, 2026

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
Published on: February 16, 2018
Highly sensitive quantitative imaging for monitoring single cancer cell growth kinetics and drug response
Mustafa Mir1, Anna Bergamaschi2, Benita S Katzenellenbogen2
1Quantitative Light Imaging Laboratory, Department of Electrical and Computer Engineering, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Abstract:
The detection and treatment of cancer has advanced significantly in the past several decades, with important improvements in our understanding of the fundamental molecular and genetic basis of the disease. Despite these advancements, drug-screening methodologies have remained essentially unchanged since the introduction of the in vitro human cell line screen in 1990. Although the existing methods provide information on the overall effects of compounds on cell viability, they are restricted by bulk measurements, large sample sizes, and lack capability to measure proliferation kinetics at the individual cell level. To truly understand the nature of cancer cell proliferation and to develop personalized adjuvant therapies, there is a need for new methodologies that provide quantitative information to monitor the effect of drugs on cell growth as well as morphological and phenotypic changes at the single cell level. Here we show that a quantitative phase imaging modality known as spatial light interference microscopy (SLIM) addresses these needs and provides additional advantages over existing proliferation assays. We demonstrate these capabilities through measurements on the effects of the hormone estradiol and the antiestrogen ICI182,780 (Faslodex) on the growth of MCF-7 breast cancer cells. Along with providing information on changes in the overall growth, SLIM provides additional biologically relevant information. For example, we find that exposure to estradiol results in rapidly growing cells with lower dry mass than the control population. Subsequently blocking the estrogen receptor with ICI results in slower growing cells, with lower dry masses than the control. This ability to measure changes in growth kinetics in response to environmental conditions provides new insight on growth regulation mechanisms. Our results establish the capabilities of SLIM as an advanced drug screening technology that provides information on changes in proliferation kinetics at the cellular level with greater sensitivity than any existing method.
Insights
Spatial Light Interference Microscopy (SLIM) offers a novel method for cancer drug screening. This advanced technique quantifies individual cell growth and phenotypic changes, surpassing traditional assays in sensitivity and detail.
Area of Science:
- Biophysics
- Cell Biology
- Cancer Research
Background:
- Cancer detection and treatment have advanced, but drug screening methods remain outdated.
- Current in vitro assays use bulk measurements, limiting single-cell kinetic and phenotypic analysis.
- New methodologies are needed for personalized cancer therapies and understanding proliferation.
Purpose of the Study:
- To introduce Spatial Light Interference Microscopy (SLIM) as an advanced drug screening technology.
- To demonstrate SLIM's capability in monitoring drug effects on cell proliferation kinetics and morphology.
- To compare SLIM's performance against existing proliferation assays.
Main Methods:
- Utilized Spatial Light Interference Microscopy (SLIM), a quantitative phase imaging modality.
- Measured the effects of estradiol and ICI182,780 (Faslodex) on MCF-7 breast cancer cell growth.
- Analyzed proliferation kinetics, dry mass, and morphological changes at the single-cell level.
Main Results:
- SLIM provided quantitative information on cell growth kinetics and dry mass changes.
- Estradiol exposure led to faster-growing cells with lower dry mass.
- ICI182,780 treatment resulted in slower growth and reduced dry mass compared to controls.
- SLIM demonstrated higher sensitivity in detecting proliferation changes than existing methods.
Conclusions:
- SLIM is a powerful tool for quantitative analysis of cell proliferation and drug response.
- The technology offers insights into growth regulation mechanisms.
- SLIM represents a significant advancement for drug screening and personalized cancer therapy development.

